HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
CLS Cat# 300194, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
CLS |
300194 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-15 05:03:34 |
39236 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued
Possibly Discontinued
|
CLS Cat# 300148, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055
PMID:71759
PMID:327080
PMID:833871
PMID:856461
PMID:922665
PMID:2535691
PMID:3518877
PMID:3698005
PMID:5459762
PMID:6401685
PMID:6888561
PMID:6935474
PMID:7037175
PMID:7139592
PMID:7253718
PMID:7459858
PMID:7838528
PMID:8221663
PMID:8490657
PMID:8665486
PMID:9201287
PMID:9283597
PMID:9516836
PMID:11550280
PMID:11668190
PMID:12210830
PMID:12702577
PMID:15390183
PMID:15892104
PMID:16524757
PMID:16822308
PMID:17974978
PMID:20655465
PMID:22213050
PMID:22460905
PMID:24466371
PMID:25485619
PMID:25877200
PMID:25894527
PMID:26589293
PMID:28350380
PMID:30894373
PMID:31068700
PMID:31581737
PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
CLS |
300148 |
BTO:BTO_0000934,
CLO:CLO_0006948,
CLO:CLO_0016777,
EFO:EFO_0001195,
MCCL:MCC:0000242,
CLDB:cl2878,
CLDB:cl2879,
CLDB:cl2880,
CLDB:cl2881,
CLDB:cl2882,
CLDB:cl2883,
CLDB:cl2885,
CLDB:cl2886,
CLDB:cl2887,
CLDB:cl2888,
ABM:T8975,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:CCL-127,
BCRC:60014,
BCRJ:0377,
BioGRID_ORCS_Cell_line:637,
BioSample:SAMN00808348,
BioSample:SAMN03472412,
BioSample:SAMN03473082,
BioSample:SAMN10988103,
cancercelllines:CVCL_0346,
CCRID:1101HUM-PUMC000282,
CCRID:3101HUMTCHu145,
CCRID:4201HUM-CCTCC00107,
CCTCC:GDC0107,
Cell_Model_Passport:SIDM00226,
CGH-DB:78-1,
CGH-DB:9095-4,
ChEMBL-Cells:CHEMBL3307656,
ChEMBL-Targets:CHEMBL614585,
CLS:300148,
Coriell:AG03320,
Coriell:GM03320,
Cosmic:688067,
Cosmic:759892,
Cosmic:801746,
Cosmic:920239,
Cosmic:922658,
Cosmic:947702,
Cosmic:1019944,
Cosmic:1037352,
Cosmic:1099149,
Cosmic:1109111,
Cosmic:1237544,
Cosmic:1518066,
Cosmic:1526626,
Cosmic:2058113,
Cosmic:2131590,
Cosmic:2301580,
Cosmic:2393630,
Cosmic:2485944,
DepMap:ACH-000310,
DSMZ:ACC-165,
DSMZCellDive:ACC-165,
ECACC:86041809,
EGA:EGAS00001000610,
GEO:GSM453632,
GEO:GSM563362,
GEO:GSM692859,
GEO:GSM887162,
GEO:GSM888234,
GEO:GSM1366406,
GEO:GSM1669934,
GEO:GSM2371237,
GEO:GSM2394364,
IARC_TP53:23585,
ICLC:HTL96021,
IZSLER:BS TCL 29,
JCRB:IFO50283,
JCRB:JCRB9050,
KCB:KCB 2011100YJ,
KCLB:10127,
LiGeA:CCLE_016,
LINCS_LDP:LCL-1965,
Lonza:971,
PharmacoDB:IMR32_659_2019,
PRIDE:PXD000589,
Progenetix:CVCL_0346,
PubChem_Cell_line:CVCL_0346,
RCB:RCB1895,
TKG:TKG 0207,
Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-08-15 05:03:35 |
353 |
TO 175.T
Resource Report
Resource Website
|
ATCC Cat# CRL-7779, RRID:CVCL_3806
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000125)..
|
PMID:20215515
PMID:22460905
PMID:25355872
PMID:26589293
PMID:30285677
PMID:30894373
PMID:31068700
|
Undefined cell line type
|
Male |
TO-175-T, TO175T |
ATCC |
CRL-7779 |
CLO:CLO_0009380,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-7779,
BioSample:SAMN03471152,
BioSample:SAMN10988143,
cancercelllines:CVCL_3806,
Cell_Model_Passport:SIDM01759,
DepMap:ACH-000125,
GEO:GSM887708,
GEO:GSM888801,
IARC_TP53:30181,
IGRhCellID:TO175T,
LiGeA:CCLE_159,
PharmacoDB:TO175_T_1602_2019,
Progenetix:CVCL_3806,
Wikidata:Q54972755 |
|
|
CVCL_3806 |
2026-08-15 05:00:04 |
0 |
TO 175.T
Resource Report
Resource Website
|
RRID:CVCL_3806
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000125)..
|
PMID:20215515
PMID:22460905
PMID:25355872
PMID:26589293
PMID:30285677
PMID:30894373
PMID:31068700
|
Undefined cell line type
|
Male |
TO-175-T, TO175T |
|
|
CLO:CLO_0009380,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-7779,
BioSample:SAMN03471152,
BioSample:SAMN10988143,
cancercelllines:CVCL_3806,
Cell_Model_Passport:SIDM01759,
DepMap:ACH-000125,
GEO:GSM887708,
GEO:GSM888801,
IARC_TP53:30181,
IGRhCellID:TO175T,
LiGeA:CCLE_159,
PharmacoDB:TO175_T_1602_2019,
Progenetix:CVCL_3806,
Wikidata:Q54972755 |
|
|
CVCL_3806 |
2026-08-15 05:00:07 |
0 |
TOV-112D
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3612
|
Homo sapiens (Human)
|
Ovarian endometrioid adenocarcinoma
|
Population: Caucasian., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10949993
PMID:11641787
PMID:16380993
PMID:18507860
PMID:19058220
PMID:19288585
PMID:20204287
PMID:22328975
PMID:22460905
PMID:22710073
PMID:22931248
PMID:24023729
PMID:25230021
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27235858
PMID:27397505
PMID:27561551
PMID:28196595
PMID:30485824
PMID:30894373
PMID:30971826
PMID:31068700
PMID:33328126
PMID:35839778
|
Cancer cell line
|
Female |
TOV-112d, TOV112D, TOV-112, TOV112 |
|
|
BTO:BTO_0005182,
CLO:CLO_0009384,
EFO:EFO_0005263,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-3593,
ATCC:CRL-11731,
BCRC:60408,
BioGRID_ORCS_Cell_line:201,
BioSample:SAMN03471348,
BioSample:SAMN10988342,
cancercelllines:CVCL_3612,
CancerTools:161766,
Cell_Model_Passport:SIDM01170,
ChEMBL-Cells:CHEMBL3707165,
ChEMBL-Targets:CHEMBL3707166,
Cosmic:875292,
Cosmic:1066219,
Cosmic:1102818,
Cosmic:1113278,
Cosmic:1139220,
Cosmic:1305335,
Cosmic:1709264,
Cosmic:2186587,
Cosmic-CLP:1299070,
DepMap:ACH-000048,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1299070,
GEO:GSE35972,
GEO:GSM274697,
GEO:GSM289383,
GEO:GSM289384,
GEO:GSM289387,
GEO:GSM289388,
GEO:GSM313690,
GEO:GSM659407,
GEO:GSM711721,
GEO:GSM784575,
GEO:GSM851944,
GEO:GSM887710,
GEO:GSM888803,
GEO:GSM1001425,
GEO:GSM1001426,
GEO:GSM1001489,
GEO:GSM1291152,
GEO:GSM1340594,
GEO:GSM1341134,
GEO:GSM1374964,
GEO:GSM1670546,
IARC_TP53:20197,
LiGeA:CCLE_580,
LINCS_LDP:LCL-1920,
PharmacoDB:TOV112D_1604_2019,
PRIDE:PXD003668,
PRIDE:PXD030304,
Progenetix:CVCL_3612,
PubChem_Cell_line:CVCL_3612,
Wikidata:Q54972795 |
|
|
CVCL_3612 |
2026-08-15 05:00:05 |
20 |
Toledo
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3611
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10485273
PMID:19278952
PMID:19358282
PMID:20215515
PMID:20628145
PMID:22460905
PMID:23292937
PMID:25355872
PMID:25485619
PMID:25877200
PMID:26589293
PMID:28196595
PMID:29416618
PMID:29666304
PMID:30165192
PMID:30285677
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
TOLEDO |
|
|
CLO:CLO_0009382,
EFO:EFO_0002383,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-2631,
BCRC:60544,
BCRJ:0235,
BioSample:SAMN03472953,
BioSample:SAMN10987633,
cancercelllines:CVCL_3611,
Cell_Model_Passport:SIDM01758,
ChEMBL-Cells:CHEMBL4295464,
ChEMBL-Targets:CHEMBL4296505,
Cosmic:1541917,
Cosmic:1670183,
Cosmic:1945195,
Cosmic:2022502,
Cosmic:2276337,
DepMap:ACH-000285,
EGA:EGAS00001000610,
GDSC:1331046,
GEO:GSM380151,
GEO:GSM552462,
GEO:GSM887709,
GEO:GSM888802,
GEO:GSM907526,
GEO:GSM1035336,
GEO:GSM3150257,
IARC_TP53:28341,
IGRhCellID:Toledo,
LiGeA:CCLE_102,
LINCS_LDP:LCL-1124,
PharmacoDB:Toledo_1603_2019,
PRIDE:PXD012087,
Progenetix:CVCL_3611,
PubChem_Cell_line:CVCL_3611,
Wikidata:Q54972777 |
|
|
CVCL_3611 |
2026-08-15 05:00:04 |
21 |
TTC-709
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_8007
|
Homo sapiens (Human)
|
Extrarenal rhabdoid tumor
|
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10602515
PMID:31068700
|
Cancer cell line
|
|
TTC 709, TTC709 |
|
|
BioSample:SAMN10989625,
Cell_Model_Passport:SIDM01455,
Cosmic:802054,
DepMap:ACH-000597,
GEO:GSM3145599,
GEO:GSM3145742,
PharmacoDB:TTC709_1608_2019,
Wikidata:Q54973253 |
|
|
CVCL_8007 |
2026-08-15 05:00:19 |
2 |
TTC-642
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_8006
|
Homo sapiens (Human)
|
Extrarenal rhabdoid tumor
|
Karyotypic information: 45,XX,-22 (PubMed=9559292)., From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile)..
|
PMID:9559292
PMID:9920784
PMID:10602515
PMID:11921280
PMID:12210830
PMID:14662021
PMID:24418192
PMID:31068700
|
Cancer cell line
|
Female |
TTC 642, TTC642 |
|
|
BioSample:SAMN10989628,
cancercelllines:CVCL_8006,
Cell_Model_Passport:SIDM01456,
Cosmic:801774,
Cosmic:802053,
Cosmic:2144785,
DepMap:ACH-001212,
GEO:GSM3145598,
GEO:GSM3145741,
Wikidata:Q54973252 |
|
|
CVCL_8006 |
2026-08-15 05:00:15 |
1 |
TUHR4TKB
Resource Report
Resource Website
1+ mentions
|
RCB Cat# RCB1198, RRID:CVCL_5957
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9914789
PMID:10929426
PMID:14534724
PMID:15604581
PMID:22185343
PMID:22460905
PMID:26589293
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
TUHR-4TKB, 4TUHR, 4T |
RCB |
RCB1198 |
BTO:BTO_0003729,
CLO:CLO_0050898,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:353,
BioSample:SAMN03472178,
BioSample:SAMN10987695,
cancercelllines:CVCL_5957,
Cell_Model_Passport:SIDM01432,
DepMap:ACH-000495,
GEO:GSM887717,
GEO:GSM888810,
IARC_TP53:30184,
LiGeA:CCLE_767,
PharmacoDB:TUHR4TKB_1612_2019,
Progenetix:CVCL_5957,
RCB:RCB1198,
Wikidata:Q54973374 |
|
|
CVCL_5957 |
2026-08-15 05:00:20 |
2 |
TUHR4TKB
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_5957
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9914789
PMID:10929426
PMID:14534724
PMID:15604581
PMID:22185343
PMID:22460905
PMID:26589293
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Male |
TUHR-4TKB, 4TUHR, 4T |
|
|
BTO:BTO_0003729,
CLO:CLO_0050898,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:353,
BioSample:SAMN03472178,
BioSample:SAMN10987695,
cancercelllines:CVCL_5957,
Cell_Model_Passport:SIDM01432,
DepMap:ACH-000495,
GEO:GSM887717,
GEO:GSM888810,
IARC_TP53:30184,
LiGeA:CCLE_767,
PharmacoDB:TUHR4TKB_1612_2019,
Progenetix:CVCL_5957,
RCB:RCB1198,
Wikidata:Q54973374 |
|
|
CVCL_5957 |
2026-08-15 05:00:18 |
2 |
TUHR14TKB
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_5953
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10929426
PMID:14534724
PMID:15604581
PMID:17212712
PMID:22460905
PMID:26589293
PMID:28489074
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
TUHR-14TKB, 14T |
|
|
BTO:BTO_0003730,
CLO:CLO_0050897,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN03472133,
BioSample:SAMN10987725,
cancercelllines:CVCL_5953,
Cell_Model_Passport:SIDM01433,
DepMap:ACH-000317,
GEO:GSM887716,
GEO:GSM888809,
IARC_TP53:28394,
LiGeA:CCLE_858,
PharmacoDB:TUHR14TKB_1611_2019,
Progenetix:CVCL_5953,
RCB:RCB1383,
Wikidata:Q54973369 |
|
|
CVCL_5953 |
2026-08-15 05:00:18 |
4 |
TUHR10TKB
Resource Report
Resource Website
1+ mentions
|
RCB Cat# RCB1275, RRID:CVCL_5952
|
Homo sapiens (Human)
|
Clear cell renal cell carcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9914789
PMID:17284252
PMID:22460905
PMID:26589293
PMID:28489074
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
TUHR-10TKB, OgTs |
RCB |
RCB1275 |
BTO:BTO_0003732,
CLO:CLO_0050896,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:354,
BioSample:SAMN03472180,
BioSample:SAMN10987736,
cancercelllines:CVCL_5952,
Cell_Model_Passport:SIDM01454,
DepMap:ACH-000459,
FANTOM5_SSTAR:10471-106I3,
GEO:GSM887715,
GEO:GSM888808,
IARC_TP53:30183,
LiGeA:CCLE_294,
PharmacoDB:TUHR10TKB_1610_2019,
Progenetix:CVCL_5952,
RCB:RCB1275,
Wikidata:Q54973368 |
|
|
CVCL_5952 |
2026-08-15 05:00:20 |
1 |
TYK-nu
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1776
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2647872
PMID:3658923
PMID:3782955
PMID:9290701
PMID:11330945
PMID:12417041
PMID:20164919
PMID:22460905
PMID:22710073
PMID:23839242
PMID:25485619
PMID:25846456
PMID:25877200
PMID:25984343
PMID:26589293
PMID:27397505
PMID:27561551
PMID:28196595
PMID:30485824
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
TYK-NU, TYKnu, TYKNU |
|
|
CLO:CLO_0037104,
EFO:EFO_0006766,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:1039,
BioSample:SAMN03471005,
BioSample:SAMN10988265,
cancercelllines:CVCL_1776,
Cell_Model_Passport:SIDM00321,
CGH-DB:9359-4,
ChEMBL-Cells:CHEMBL3308805,
ChEMBL-Targets:CHEMBL1075601,
Cosmic:909774,
Cosmic:931359,
Cosmic:948288,
Cosmic:1077283,
Cosmic:2582803,
Cosmic:2674702,
Cosmic-CLP:909774,
DepMap:ACH-000430,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:909774,
GEO:GSM659409,
GEO:GSM711725,
GEO:GSM851946,
GEO:GSM887718,
GEO:GSM888811,
GEO:GSM1670552,
IARC_TP53:27264,
JCRB:JCRB0234.0,
LiGeA:CCLE_471,
LINCS_LDP:LCL-1700,
PharmacoDB:TYKnu_1614_2019,
PRIDE:PXD003668,
PRIDE:PXD030304,
Progenetix:CVCL_1776,
PubChem_Cell_line:CVCL_1776,
Wikidata:Q54973461 |
|
|
CVCL_1776 |
2026-08-15 05:00:21 |
13 |
U-343MGa
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4773
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3497714
PMID:10709103
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
U-343 MG-A, U-343-MG-A, U343-MG-A, U-343 MGa, U343 MGa, U343MGa, U343 |
|
|
BTO:BTO_0003218,
CLO:CLO_0009459,
CLDB:cl4586,
BioGRID_ORCS_Cell_line:350,
BioSample:SAMN10988401,
Cell_Model_Passport:SIDM01421,
CLS:300365,
DepMap:ACH-000036,
PharmacoDB:U343_1631_2019,
Wikidata:Q54973569 |
|
|
CVCL_4773 |
2026-08-15 05:00:21 |
1 |
U-178MG
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_A758
|
Homo sapiens (Human)
|
Astrocytoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569
PMID:450131
PMID:833871
PMID:1847665
PMID:2454731
PMID:3518877
PMID:4134536
PMID:4139097
PMID:4369403
PMID:10416987
PMID:10560660
PMID:19435942
PMID:22570425
PMID:25984343
PMID:27582061
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
U-178-MG, U-178 MG, U178-MG, U 178 MG, U178MG, MG 178, U-178, 178 MG, 178MG, 178 MG(5) |
|
|
EFO:EFO_0022627,
BioGRID_ORCS_Cell_line:692,
BioSample:SAMN10988405,
cancercelllines:CVCL_A758,
Cell_Model_Passport:SIDM01431,
Cosmic:849851,
Cosmic:849879,
Cosmic:1610740,
Cosmic:2516041,
DepMap:ACH-000208,
PharmacoDB:U178_1618_2019,
Progenetix:CVCL_A758,
Wikidata:Q54973519 |
|
|
CVCL_A758 |
2026-08-15 05:00:21 |
2 |
U-138MG
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0020
|
Homo sapiens (Human)
|
Astrocytoma
|
Population: Caucasian., Part of: Human Protein Atlas, Cell Atlas panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:450131
PMID:833871
PMID:2454731
PMID:3518877
PMID:3675803
PMID:4134536
PMID:4313504
PMID:4337530
PMID:4369403
PMID:6220172
PMID:6260907
PMID:6582512
PMID:9842975
PMID:10416987
PMID:14614447
PMID:14655754
PMID:14961077
PMID:16697959
PMID:16957166
PMID:17595512
PMID:19365568
PMID:19435942
PMID:20215515
PMID:22282976
PMID:22460905
PMID:22570425
PMID:27582061
PMID:30894373
PMID:31068700
PMID:33385022
|
Cancer cell line
|
Male |
U-138 MG, U-138-MG, U138-MG, U 138 MG, U138MG, U138, 138 MG, 138MG |
|
|
BTO:BTO_0002127,
CLO:CLO_0009452,
CLO:CLO_0009453,
CLDB:cl4577,
ArrayExpress:E-MTAB-38,
ATCC:HTB-16,
BCRJ:0239,
BioGRID_ORCS_Cell_line:1536,
BioSample:SAMN01821604,
BioSample:SAMN01821668,
BioSample:SAMN03472727,
BioSample:SAMN10987758,
cancercelllines:CVCL_0020,
Cell_Model_Passport:SIDM01192,
ChEMBL-Cells:CHEMBL4295387,
ChEMBL-Targets:CHEMBL4296506,
CLS:300363,
Cosmic:755288,
Cosmic:850744,
Cosmic:1571920,
Cosmic:1610739,
Cosmic:1746952,
Cosmic:2060806,
Cosmic:2301555,
Cosmic:2302317,
Cosmic:2580917,
Cosmic:2701085,
DepMap:ACH-001214,
DSMZ:ACC-291,
DSMZCellDive:ACC-291,
GEO:GSM101673,
GEO:GSM101674,
GEO:GSM326234,
GEO:GSM887719,
GEO:GSM888813,
GEO:GSM7701433,
GEO:GSM7701434,
IGRhCellID:U138MG,
LINCS_LDP:LCL-1359,
Lonza:104,
PharmacoDB:U138MG_1617_2019,
Progenetix:CVCL_0020,
PubChem_Cell_line:CVCL_0020,
Wikidata:Q54973513 |
|
|
CVCL_0020 |
2026-08-15 05:00:21 |
15 |
U-BLC1
Resource Report
Resource Website
|
RRID:CVCL_2738
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10074925
PMID:24035680
PMID:24367658
PMID:26589293
PMID:29732388
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Female |
UBLC1 |
|
|
ArrayExpress:E-MTAB-2770,
BioSample:SAMN10987727,
cancercelllines:CVCL_2738,
Cell_Model_Passport:SIDM01757,
Cosmic:2050467,
Cosmic:2212693,
DepMap:ACH-000741,
ECACC:06013102,
IARC_TP53:28257,
IARC_TP53:28265,
LiGeA:CCLE_374,
PharmacoDB:UBLC1_1625_2019,
Wikidata:Q54973609 |
|
|
CVCL_2738 |
2026-08-15 05:00:22 |
0 |
U-251MG
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0021
|
Homo sapiens (Human)
|
Astrocytoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569
PMID:450131
PMID:608846
PMID:833871
PMID:2041050
PMID:3335022
PMID:3518877
PMID:3675803
PMID:4134536
PMID:4369403
PMID:6260907
PMID:6582512
PMID:7693337
PMID:7763724
PMID:8104691
PMID:8878451
PMID:9090379
PMID:9220028
PMID:9230885
PMID:9331090
PMID:9614553
PMID:9842975
PMID:10416987
PMID:10551321
PMID:10560660
PMID:10700174
PMID:14614447
PMID:14655754
PMID:15748285
PMID:15900046
PMID:16232199
PMID:16391870
PMID:16697959
PMID:16957166
PMID:17088437
PMID:17595512
PMID:19372543
PMID:19435942
PMID:20215515
PMID:20593219
PMID:22068913
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22570425
PMID:22628656
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:24810477
PMID:25894527
PMID:25960936
PMID:25984343
PMID:27377824
PMID:27397505
PMID:27582061
PMID:27807467
PMID:28196595
PMID:29716531
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31733513
PMID:33385022
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Male |
U-251 MG, U-251-MG, U-251_MG, U251-MG, U251MG, U-251, U251, U251n, U251N, 251 MG, 251MG, 251 MG(6) |
|
|
BTO:BTO_0002035,
CLO:CLO_0009456,
EFO:EFO_0006498,
CLDB:cl4583,
AddexBio:C0005029/5016,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:351,
BioSample:SAMN10988290,
cancercelllines:CVCL_0021,
CCRID:1101HUM-PUMC000058,
CCRID:3101HUMTCHu58,
CCRID:4201HUM-CCTCC00093,
CCTCC:GDC0093,
Cell_Model_Passport:SIDM00111,
CGH-DB:155-1,
ChEMBL-Cells:CHEMBL3307756,
ChEMBL-Targets:CHEMBL615022,
CLS:300385,
Cosmic:687451,
Cosmic:848340,
Cosmic:849850,
Cosmic:850742,
Cosmic:875896,
Cosmic:897440,
Cosmic:905983,
Cosmic:920818,
Cosmic:923899,
Cosmic:970094,
Cosmic:974243,
Cosmic:1044250,
Cosmic:1066235,
Cosmic:1092644,
Cosmic:1171225,
Cosmic:1175823,
Cosmic:1217673,
Cosmic:1312345,
Cosmic:1436038,
Cosmic:1610741,
Cosmic:1998487,
Cosmic:2367502,
Cosmic:2367554,
Cosmic:2516042,
Cosmic:2550363,
Cosmic:2580916,
Cosmic-CLP:905983,
DepMap:ACH-000232,
ECACC:09063001,
EGA:EGAS00001000978,
GDSC:905983,
GEO:GSE66597,
GEO:GSM2103,
GEO:GSM50180,
GEO:GSM50244,
GEO:GSM101675,
GEO:GSM101677,
GEO:GSM101678,
GEO:GSM101679,
GEO:GSM101680,
GEO:GSM101685,
GEO:GSM743440,
GEO:GSM750795,
GEO:GSM799328,
GEO:GSM799391,
GEO:GSM844718,
GEO:GSM844719,
GEO:GSM847166,
GEO:GSM887720,
GEO:GSM888814,
GEO:GSM1153398,
GEO:GSM1178662,
GEO:GSM1178663,
GEO:GSM1181247,
GEO:GSM1181342,
GEO:GSM1670555,
GEO:GSM2124691,
GEO:GSM7701412,
GEO:GSM7701413,
Hysigen:TCH-C366,
IARC_TP53:2575,
ICLC:HTL99014,
JCRB:IFO50288,
KCB:KCB 200965YJ,
Kerafast:EDK001,
LiGeA:CCLE_040,
LINCS_LDP:LCL-1400,
Lonza:105,
Lonza:1007,
MetaboLights:MTBLS6212,
NCI-DTP:U-251,
PharmacoDB:U251MG_1629_2019,
PRIDE:PXD000589,
PRIDE:PXD003539,
PRIDE:PXD005940,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_0021,
PubChem_Cell_line:CVCL_0021,
RCB:RCB0461,
SKY/M-FISH/CGH:2825,
TOKU-E:4005,
Ubigene:YC-D015,
Wikidata:Q54973550 |
|
|
CVCL_0021 |
2026-08-15 05:00:22 |
4639 |
U2OS
Resource Report
Resource Website
5000+ mentions
|
RRID:CVCL_0042
|
Homo sapiens (Human)
|
Osteosarcoma
|
Virology: Reliable and efficient in vitro integration system for human herpesvirus 6A (HHV-6A) and 6B (HHV-6B) (PubMed=28468878)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569
PMID:833871
PMID:2233717
PMID:2823272
PMID:3518877
PMID:6081590
PMID:7017212
PMID:8040301
PMID:8275086
PMID:8617485
PMID:12645653
PMID:15150091
PMID:15736406
PMID:16957166
PMID:17354236
PMID:17981215
PMID:18359981
PMID:19787792
PMID:20164919
PMID:20215515
PMID:21519327
PMID:22068332
PMID:22278370
PMID:22460905
PMID:23144859
PMID:23649806
PMID:24136885
PMID:24618588
PMID:25485619
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26351324
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28468878
PMID:29853780
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Female |
U-2 OS, U-2OS, U-2-OS, U2-OS, U20-S, U20S, 2T |
|
|
BTO:BTO_0001938,
CLO:CLO_0001272,
CLO:CLO_0009454,
EFO:EFO_0002869,
MCCL:MCC:0000468,
CLDB:cl53,
CLDB:cl4579,
CLDB:cl4580,
CLDB:cl4581,
CLDB:cl7217,
4DN:4DNSR3V9ST6H,
Abcam:ab263976,
Abcam:ab279979,
ABM:T8293,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-96,
BCRC:60187,
BCRJ:0304,
BioGRID_ORCS_Cell_line:265,
BioSample:SAMN03472549,
BioSample:SAMN03472766,
BioSample:SAMN10987914,
cancercelllines:CVCL_0042,
CCRID:1101HUM-PUMC000028,
CCRID:3101HUMSCSP5030,
CCRID:3101HUMTCHu88,
CCRID:4201HUM-CCTCC00626,
CCRID:5301HUM-KCB09062YJ,
Cell_Model_Passport:SIDM01191,
ChEMBL-Cells:CHEMBL3307757,
ChEMBL-Targets:CHEMBL615023,
CLS:300364,
Cosmic:687934,
Cosmic:755312,
Cosmic:909776,
Cosmic:931038,
Cosmic:931909,
Cosmic:1044081,
Cosmic:1044268,
Cosmic:1066238,
Cosmic:1074397,
Cosmic:1078392,
Cosmic:1082493,
Cosmic:1097758,
Cosmic:1529905,
Cosmic:1733128,
Cosmic:2009542,
Cosmic:2301583,
Cosmic:2440477,
Cosmic:2816207,
Cosmic-CLP:909776,
DepMap:ACH-000364,
DSMZ:ACC-785,
DSMZCellDive:ACC-785,
ECACC:92022711,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS200HLU,
ENCODE:ENCBS266AAA,
ENCODE:ENCBS953RZO,
GDSC:909776,
GEO:GSE54820,
GEO:GSM170250,
GEO:GSM185160,
GEO:GSM185161,
GEO:GSM287989,
GEO:GSM287990,
GEO:GSM320831,
GEO:GSM827583,
GEO:GSM879223,
GEO:GSM887722,
GEO:GSM888816,
GEO:GSM1231597,
GEO:GSM1231598,
GEO:GSM1231599,
GEO:GSM1231600,
GEO:GSM1231601,
GEO:GSM1231602,
GEO:GSM1231603,
GEO:GSM1231604,
GEO:GSM1231605,
GEO:GSM1231606,
GEO:GSM1231607,
GEO:GSM1231608,
GEO:GSM1231609,
GEO:GSM1231610,
GEO:GSM1356565,
GEO:GSM1356566,
GEO:GSM1356567,
GEO:GSM1356568,
GEO:GSM1356569,
GEO:GSM1356570,
GEO:GSM1356571,
GEO:GSM1356572,
GEO:GSM1356573,
GEO:GSM1356574,
GEO:GSM1356575,
GEO:GSM1356576,
GEO:GSM1356577,
GEO:GSM1356578,
GEO:GSM1356579,
GEO:GSM1356580,
GEO:GSM1356581,
GEO:GSM1356582,
GEO:GSM1356583,
GEO:GSM1356584,
GEO:GSM1356585,
GEO:GSM1356586,
GEO:GSM1356587,
GEO:GSM1670557,
GEO:GSM1676324,
GEO:GSM1701657,
GEO:GSM7701414,
GEO:GSM7701415,
GEO:GSM7701442,
GEO:GSM7701443,
IARC_TP53:27710,
ICLC:HTL11001,
KCB:KCB 200962YJ,
KCLB:30096,
LiGeA:CCLE_160,
LINCS_LDP:LCL-1431,
Lonza:676,
MetaboLights:MTBLS247,
MetaboLights:MTBLS292,
PharmacoDB:U2OS_1619_2019,
PRIDE:PRD000118,
PRIDE:PXD000157,
PRIDE:PXD000262,
PRIDE:PXD000589,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD001220,
PRIDE:PXD002073,
PRIDE:PXD002117,
PRIDE:PXD002395,
PRIDE:PXD003754,
PRIDE:PXD009668,
PRIDE:PXD017130,
PRIDE:PXD020622,
PRIDE:PXD024796,
PRIDE:PXD025890,
PRIDE:PXD028992,
PRIDE:PXD030166,
PRIDE:PXD030304,
PRIDE:PXD030644,
Progenetix:CVCL_0042,
PubChem_Cell_line:CVCL_0042,
TOKU-E:3379,
Ubigene:YC-C030,
Wikidata:Q28473037 |
|
|
CVCL_0042 |
2026-08-15 05:00:24 |
8982 |
U266B1
Resource Report
Resource Website
500+ mentions
Possibly Discontinued
|
RRID:CVCL_0566
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine., Characteristics: Produces IgE lambda., Population: Caucasian., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Hybridoma fusion partner cell line.
|
PMID:1373872
PMID:1643757
PMID:1720489
PMID:2140233
PMID:2537114
PMID:2985879
PMID:3159941
PMID:3874327
PMID:4097745
PMID:4104421
PMID:6350451
PMID:8943038
PMID:9685479
PMID:10087940
PMID:10557056
PMID:10583232
PMID:10936422
PMID:11154231
PMID:11157491
PMID:11429052
PMID:14555701
PMID:15215163
PMID:16956823
PMID:17171682
PMID:17229644
PMID:17692805
PMID:18647998
PMID:20164919
PMID:20215515
PMID:21173094
PMID:22460905
PMID:22806891
PMID:23074853
PMID:23992230
PMID:25485619
PMID:25688540
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30285677
PMID:30545397
PMID:30894373
PMID:31068700
PMID:31160637
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Male |
U266-B1, U266 B1, U-266, U 266, U266, U266S, U266BL, U266 Bl, 266 Bl |
|
|
BTO:BTO_0001594,
CLO:CLO_0009457,
CLO:CLO_0009458,
EFO:EFO_0001254,
MCCL:MCC:0000471,
CLDB:cl4584,
CLDB:cl4609,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ArrayExpress:E-TABM-937,
ATCC:TIB-196,
BCRC:60437,
BCRJ:0240,
BioSample:SAMN01821605,
BioSample:SAMN01821669,
BioSample:SAMN03472935,
BioSample:SAMN10987866,
cancercelllines:CVCL_0566,
CCRID:1101HUM-PUMC000684,
CCRID:4201HUM-CCTCC00325,
CCTCC:GDC0301,
CCTCC:GDC0325,
Cell_Model_Passport:SIDM00417,
CGH-DB:37-1,
CGH-DB:9155-4,
ChEMBL-Cells:CHEMBL3308535,
ChEMBL-Targets:CHEMBL2366315,
CLS:300259,
Cosmic:720795,
Cosmic:742953,
Cosmic:753615,
Cosmic:759903,
Cosmic:759912,
Cosmic:760401,
Cosmic:760647,
Cosmic:886087,
Cosmic:888019,
Cosmic:991555,
Cosmic:1424220,
Cosmic:1483078,
Cosmic:1762463,
Cosmic:1889513,
Cosmic:2081409,
Cosmic:2159571,
Cosmic:2367281,
Cosmic:2391806,
Cosmic:2809754,
Cosmic-CLP:753615,
DepMap:ACH-000626,
DSMZ:ACC-9,
DSMZCellDive:ACC-9,
ECACC:85051003,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:753615,
GEO:GSM143345,
GEO:GSM545498,
GEO:GSM545499,
GEO:GSM562821,
GEO:GSM827442,
GEO:GSM887721,
GEO:GSM888815,
GEO:GSM1374970,
GEO:GSM1670556,
IARC_TP53:361,
IARC_TP53:30185,
IBRC:C10148,
IGRhCellID:U266B1,
IZSLER:BS TCL 233,
KCB:KCB 2013024YJ,
LiGeA:CCLE_465,
LINCS_LDP:LCL-2050,
Lonza:106,
Lonza:807,
NCBI_Iran:C151,
PharmacoDB:U266B1_1630_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0566,
PubChem_Cell_line:CVCL_0566,
Wikidata:Q54973634 |
|
|
CVCL_0566 |
2026-08-15 05:00:23 |
676 |
